Phenotypic and functional characterisation of locally produced natural killer cells ex vivo expanded with the K562-41BBL-mbIL21 cell line

被引:0
|
作者
Tatsiana V. Shman
Katsiaryna P. Vashkevich
Alexandr A. Migas
Mikhail A. Matveyenka
Yauheni A. Lasiukov
Nastassia S. Mukhametshyna
Katsiaryna I. Horbach
Olga V. Aleinikova
机构
[1] Belarusian Research Center for Pediatric Oncology,
[2] Hematology and Immunology,undefined
来源
Clinical and Experimental Medicine | 2023年 / 23卷
关键词
Natural killer cells; Ex vivo expansion; Adoptive immunotherapy; Leukaemia;
D O I
暂无
中图分类号
学科分类号
摘要
We characterised the expansion, phenotype and functional activity of natural killer (NK) cells obtained for a clinical trial. Nineteen expansion procedures were performed to obtain NK cell products for 16 patients. NK cells were expanded ex vivo from haploidentical donor peripheral blood mononuclear cells in the presence of the locally generated feeder cell line K-562 with ectopic expression of 4-1BBL and mbIL-21. The median duration of expansion was 18 days (interquartile range 15–19). The median number of live cells yielded was 2.26 × 109 (range 1.6–3.4 × 109) with an NK content of 96.6% (range 95.1–97.9%). The median NK cell fold expansion was 171 (range 124–275). NK cell fold expansion depended on the number of seeded NK cells, the initial level of C-myc expression and the initial number of mature and immature NK cells. The majority of expanded NK cells had the phenotype of immature activated cells (NKG2A + , double bright CD56 +  + CD16 +  + , CD57-) expressing NKp30, NKp44, NKp46, NKG2D, CD69, HLA-DR and CD96. Despite the expression of exhaustion markers, expanded NK cells exhibited high cytolytic activity against leukaemia cell lines, high degranulation activity and cytokine production. There was a noted decrease in the functional activity of NK cells in tests against the patient’s blasts.
引用
收藏
页码:2551 / 2560
页数:9
相关论文
共 9 条
  • [1] Phenotypic and functional characterisation of locally produced natural killer cells ex vivo expanded with the K562-41BBL-mbIL21 cell line
    Shman, Tatsiana V.
    Vashkevich, Katsiaryna P.
    Migas, Alexandr A.
    Matveyenka, Mikhail A.
    Lasiukov, Yauheni A.
    Mukhametshyna, Nastassia S.
    Horbach, Katsiaryna I.
    Aleinikova, Olga V.
    CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (06) : 2551 - 2560
  • [2] SIGNIFICANT EX-VIVO EXPANSION OF CORD BLOOD (CB) NATURAL KILLER (NK) CELLS AND CONCOMITANT DECREASE IN CB T-CELLS BY GENETICALLY REENGINEERED K562 CELLS (K562-MBIL15-41BBL)
    Hochberg, J.
    Mar, B.
    Ayello, J.
    Day, N.
    van de Ven, C.
    Ricci, A.
    Gurnani, L.
    Cairo, E.
    Campana, D.
    Cairo, M. S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 44 - 45
  • [3] An Uncoupling of Canonical Phenotypic Markers and Functional Potency of Ex Vivo-Expanded Natural Killer Cells
    Lieberman, Nicole A. P.
    DeGolier, Kole
    Haberthur, Kristen
    Chinn, Harrison
    Moyes, Kara W.
    Bouchlaka, Myriam N.
    Walker, Kirsti L.
    Capitini, Christian M.
    crane, Courtney A.
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [4] Significant Ex-Vivo Expansion and Functional Activation of Cord Blood (CB) Natural Killer (NK) Cells with A Concomittant Significant Decrease in CB T Cells Following Stimulation with Genetically Engineered K562 Cells (K562-mb15-41BBL).
    Hochberg, Jessica
    Ayello, Janet
    VandeVen, Carmella
    Gold, Jeremy
    Cairo, Evan
    Zhao, Frances
    Cairo, Mitchell S.
    BLOOD, 2009, 114 (22) : 206 - 206
  • [5] Ex-Vivo Expansion of Previously Cryopreserved, Thawed and Re-Cryopreserved Cord Blood Mononuclear Cells (CBMC) Utilizing K562-mbIL21-41BBL; Potential for Adoptive Cellular Immunotherapy Post Umbilical Cord Blood Transplantation (UCBT)
    Flower, Allyson
    Chu, Yaya
    Ayello, Janet
    Kurtzberg, Joanne
    Lee, Dean
    Cairo, Mitchell S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S153 - S153
  • [6] An Extended Flow Cytometry Evaluation of ex Vivo Expanded NK Cells Using K562.Clone1, a Feeder Cell Line Manufactured in Brazil
    Watanabe, Caroline Mitika
    Suzuki, Caroline Ishihama
    dos Santos, Alessandro Marins
    Aloia, Thiago Pinheiro Arrais
    Lee, Grace
    Wald, David
    Okamoto, Oswaldo Keith
    de Azevedo, Julia T. Cottas
    de Godoy, Juliana Aparecida Preto
    Santos, Fabio P. S.
    Weinlich, Ricardo
    Kerbauy, Lucila N.
    Kutner, Jose Mauro
    Paiva, Raquel de Melo Alves
    Hamerschlak, Nelson
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (11): : 1063e1 - 1063e19
  • [7] ENHANCED CORD BLOOD (CB) NATURAL KILLER (NK) CELL EXPANSION, ACTIVATION, AND CYTOLYTIC ACTIVITY IN-VITRO AND IN-VIVO AGAINST B-NHL FOLLOWING STIMULATION WITH GENETICALLY REENGINEERED K562MBIL15-41BBL (MODK562): POTENTIAL FOR ADOPTIVE CELLULAR IMMUNOTHERAPY IN B-NHL
    Cairo, M.
    Ayello, J.
    Levin, M.
    Hochberg, J.
    Zhao, F.
    Chu, Y.
    Vandeven, C.
    ANNALS OF ONCOLOGY, 2011, 22 : 198 - 198
  • [8] Genetically Reengineered K562 Cells Significantly Expand Cord Blood (CB) Natural Killer (NK) Cells Ex-Vivo Expanded with Increased NK Cell Activation and Cytolytic Activity Both In-Vitro and In-Vivo: Potential Use In Adoptive Cellular Immunotherapy (ACI)
    Levin, Michele
    Ayello, Janet
    Zhao, Frances
    Stier, Andrew
    Tiffen, Lauren
    Quish, William
    vandeVen, Carmella
    Baxi, Laxmi V.
    Hochberg, Jessica
    Cairo, Mitchell S.
    BLOOD, 2010, 116 (21) : 1602 - 1602
  • [9] Defective killing activity against gp120/41-expressing human erythroleukaemic K562 cell line by monocytes and natural killer cells from HIV-infected individuals
    Ahmad, A
    Menezes, J
    AIDS, 1996, 10 (02) : 143 - 149